ClinicalTrials.gg
CompletedNCT07155109Updated Oct 15, 2026

Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Surgeries

An interventional study of Low pressure group and Normal pressure group in Intracranial Pressure Increase, Abdominal Pain and Head Pain, sponsored by Diskapi Yildirim Beyazit Education and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Diskapi Yildirim Beyazit Education and Research Hospital · Not applicable, Interventional, and Other

How we know

Updated Oct 15, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
99
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Intracranial Hypertension with a site in Turkey — 4 open to participants now, 4 under way, none of them phase 3. Intracranial Hypertension · Turkey.

Enrollment
2nd of 18
99 · median 60
Started
2025
with 1 other
No phase
18 of 26
1 open now
Registered
24th of 26
by date

Among the 26 studies in Intracranial Hypertension with a site in Turkey, this one is the 2nd largest by enrollment of the 18 interventional ones that give a count, is one of 2 that started in 2025, is one of 18 with no phase, and was the 24th registered.

Intracranial Hypertension

166 studies on the registry are indexed under Intracranial Hypertension; 37 are open to participants now.

Browse Intracranial Hypertension studies →

Open to participants now

4 of the 26 studies in Intracranial Hypertension with a site in Turkey are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 23 Intracranial Hypertension studies recruiting now, 11 (48%) set no upper age limit and 5 (22%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 65 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Intracranial Hypertension with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to investigate the effects of low and normal intraperitoneal pressures on intraoperative optic nerve sheath diameter in laparoscopic gyneco-oncologic surgeries.

Read the detailed description

Gynecological surgeries are minimally invasive procedures. The establishment of pneumoperitoneum, special patient positioning, and surgical stimulation can induce a stress response in patients. Carbon dioxide (CO₂) pneumoperitoneum and the Trendelenburg position lead to increases in intra-abdominal, intrathoracic, and airway pressures, which in turn may directly or indirectly cause elevations in intracranial and intraocular pressures.

During the perioperative period, the optic nerve sheath diameter (ONSD), measured ultrasonographically, is used as a reliable method to estimate intracranial pressure (ICP). Monitoring ICP under anesthesia may help prevent neurological complications such as neurological deterioration and optic neuropathy. Furthermore, studies have demonstrated ICP changes in robotic and laparoscopic gynecologic surgeries through ultrasonographic measurement of ONSD.

Traditionally, laparoscopic abdominal surgeries are performed using intraperitoneal pressures ranging between 10 and 18 mmHg. Lower intra-abdominal pressures have been associated with reduced postoperative pain, improved pulmonary parameters, and a decreased risk of gas embolism. However, the data on these outcomes remain limited.

In this study, investigators aimed to investigate the effect of pressures above and below 12 mmHg on the optic nerve sheath diameter-and consequently on intracranial pressure-in patients undergoing laparoscopic gynecologic surgery.

03

Conditions studied

  • Intracranial Pressure Increase
  • Abdominal Pain
  • Head Pain

Keywords

  • Intracranial Pressure
  • optic nerve
  • laparascopy
  • gyneco-oncologic surgery
  • low pressure
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Laparoscopic gyneco-oncological surgeries
  • Female patients aged 18-65 years
  • classification I-II-III patients

Exclusion criteria

Exclusion Criteria:

  • Patients with diabetic retinopathy
  • Patients with glaucoma
  • Patients with cerebrovascular disease
  • Pregnant women
  • Patients with known allergy to anaesthetic agents
  • Morbidly obese patients with > 40
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
99 participants (actual)

Study arms

  • Experimental
    Low Pressure Group

    In laparoscopic gyneco-oncological surgeries, low pressure group received below 12 mmHg intraperitoneal pressure.

    Other: Low pressure group

  • Experimental
    Normal Pressure Group

    In laparoscopic gyneco-oncological surgeries, normal pressure group received 12 and abowe 12 mmHg intraperitoneal pressure.

    Other: Normal pressure group

Interventions

  • OtherLow pressure group

    In laparoscopic gyneco-oncological surgeries, low pressure group will receive below 12 mmHg intraperitoneal pressure.

  • OtherNormal pressure group

    In laparoscopic gyneco-oncological surgeries, normal pressure group will receive 12 and abowe 12 mmHg intraperitoneal pressure.

06

What researchers measure

Primary outcomes

  1. Measurement of optic nerve sheath diameter (ONSD)

    ONSD will be measured in the supine position by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.

    Time frame: 30 minutes after introducing pneumoperitoneum and position change

Secondary outcomes

  1. Measurement of optic nerve sheath diameter (ONSD)

    ONSD will be measured by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.

    Time frame: The baseline ONSD measurement will be performed 5 minutes after endotracheal intubation

  2. Measurement of optic nerve sheath diameter (ONSD)

    ONSD will be measured in the supine position by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.

    Time frame: 5 minutes after introducing pneumoperitoneum and position change

  3. Measurement of optic nerve sheath diameter (ONSD)

    ONSD will be measured by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.

    Time frame: 60 minutes after introducing pneumoperitoneum and position change

  4. Measurement of optic nerve sheath diameter (ONSD)

    ONSD will be measured by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.

    Time frame: 90 minutes after introducing pneumoperitoneum and position change

  5. Measurement of optic nerve sheath diameter (ONSD)

    ONSD will be measured in the supine position by ulrasonographic measurement.After obtaining optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band, the ONSD will be measured 3 mm behind the optic disc using an electronic caliper. The final ONSD value was calculated by averaging 4 measured values: measured values of transverse and sagittal plane of both eyes.

    Time frame: The ONSD measurement will be performed 5 minutes after the pneumoperitoneum is released and the Trendelenburg position is corrected.

Other outcomes

  1. numerical rating scale (NRS) at rest

    Recording the patient's pain at rest on the Numerical Rating Scale (NRS) by asking the patient

    Time frame: popstoperative 1. hour

  2. numerical rating scale (NRS) at rest

    Recording the patient's pain at rest on the Numerical Rating Scale (NRS) by asking the patient

    Time frame: popstoperative 8. hours

  3. postoperative nosia and vomiting (PONV)

    Recording the presence or absence of nausea and vomiting in the patient within the first 24 hours postoperatively

    Time frame: popstoperative 1. hour

  4. postoperative nosia and vomiting (PONV)

    Recording the presence or absence of nausea and vomiting in the patient within the first 24 hours postoperatively

    Time frame: popstoperative 8. hours

  5. headache

    The presence or absence of headache will be assessed and documented.

    Time frame: popstoperative 8. hours

07

Study locations

1 site
  • Zeynep Koç
    Yenimahalle, Ankara, Turkey (Türkiye)
08

References and documents

Publications

  • Lee YY, Lee H, Park HS, Kim WJ, Baik HJ, Kim DY. Optic nerve sheath diameter changes during gynecologic surgery in the Trendelenburg position: comparison of propofol-based total intravenous anesthesia and sevoflurane anesthesia. Anesth Pain Med (Seoul). 2019 Oct 31;14(4):393-400. doi: 10.17085/apm.2019.14.4.393. PubMed 33329767 ↗
  • Geng W, Chen C, Sun X, Huang S. Effects of sevoflurane and propofol on the optic nerve sheath diameter in patients undergoing laparoscopic gynecological surgery: a randomized controlled clinical studies. BMC Anesthesiol. 2021 Jan 27;21(1):30. doi: 10.1186/s12871-021-01243-7. PubMed 33504329 ↗
  • Kim SH, Kim HJ, Jung KT. Position does not affect the optic nerve sheath diameter during laparoscopy. Korean J Anesthesiol. 2015 Aug;68(4):358-63. doi: 10.4097/kjae.2015.68.4.358. Epub 2015 Jul 28. PubMed 26257848 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Feb 2026, 5 months.

Of 37 non-industry interventional studies with no phase under Intracranial Hypertension, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 39. This study's 5 months is below that.

Counting every sponsor, half of 38 studies reached it within 18 months; a quarter within 6 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Oct 2025 → Feb 2026 and completion Oct 2025 → Mar 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2025
First posted
Sep 4, 2025
StartActual
Aug 30, 2025
Primary completionActual
Feb 10, 2026was Oct 2025
CompletionActual
Mar 20, 2026was Oct 2025
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Oct 15, 2026
Primary completion
Oct 10, 2025→Feb 10, 2026 (actual)
Oct 15, 2026
Study completion
Oct 20, 2025→Mar 20, 2026 (actual)
Oct 15, 2026
Enrollment
100 (estimated)→99 (actual)
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Not yet recruiting→Completed
    Primary completion Oct 10, 2025→Feb 10, 2026 (now actual)
    Study completion Oct 20, 2025→Mar 20, 2026 (now actual)
    Enrollment 100 (estimated)→99 (actual)
    + 4 other changes: verification date, description, contact details and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07155109
Lead sponsor
Diskapi Yildirim Beyazit Education and Research Hospital
Responsible party
Zeynep Koc (principal investigator, Diskapi Yildirim Beyazit Education and Research Hospital) — Principal investigator
First posted
Sep 4, 2025
Start date
Aug 30, 2025
Primary completion
Feb 10, 2026
Completion
Mar 20, 2026
Last update
Oct 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion